[1]
“Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy”, GJMR, vol. 19, no. F6, pp. 17–20, Nov. 2019, Accessed: Oct. 22, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/1872